Results 161 to 170 of about 22,974 (229)

Authors' response to comments on "Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis". [PDF]

Korean J Pain
Hariyanto TI, Vatvani AD, Patel P, Yanto TA.   +3 more
europepmc   +1 more source

Synthesis, Opioid Receptor Binding, and Biological Activities of Naltrexone-Derived Pyrido- and Pyrimidomorphinans

, 1999
Subramaniam Ananthan, Hollis S. Kezar, Ronald L. Carter, Surendra Kumar Saini, Kenner C. Rice, Jennifer Wells, Peg Davis, Heng Xu, Christina M. Dersch, Edward J. Bilsky, Frank Porreca, Richard B. Rothman   +11 more
openalex   +1 more source

Naltrexone Has Variable and Schedule-Dependent Effects on Oral Squamous Cell Carcinoma Cells. [PDF]

Int J Mol Sci
Kazmi S, Sanford E, Rammaha ZA, Bengson EJ, Gao F, Sangalli L, Roberts CM.   +6 more
europepmc   +1 more source

Applicability of the New Zealand-eating behavior questionnaire to predict weight loss responses to naltrexone/bupropion: a proof-of-concept trial. [PDF]

Obes Pillars
Schmiedel O, Ivey M, Karunasinghe N, Murphy R.   +3 more
europepmc   +1 more source

Human Skin Sermeation of 3-O-Alkyl Carbamate Prodrugs of Naltrexone

, 2008
H.K Vaddi, Stan L. Banks, Jianhong Chen, Dana C. Hammell, Peter A. Crooks, Audra L. Stinchcomb   +5 more
openalex   +2 more sources

Buprenorphine Treatment Duration and Adherence Among Youth and Subsequent Health Outcomes. [PDF]

Pediatrics
Hadland SE, Kimmel SD, Yan S, Bettano AL, Lo-Ciganic WH, Bagley SM, Calihan JB, Hsu HE, Larochelle MR.   +8 more
europepmc   +1 more source

Naltrexone-induced skin lesions in a patient with alcohol use disorder.

Ind Psychiatry J
Rikhari P, Chaubey AN.
europepmc   +1 more source

Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported. [PDF]

Korean J Pain
Bruun KD, Nielsen MJ, Vaegter HB, Blichfeldt-Eckhardt MR, Amris K, Pedersen JR.   +5 more
europepmc   +1 more source

266. OPRM1 A118G POLYMORPHISMS AND NALTREXONE TREATMENT RESPONSE AMONG TAIWANESE PATIENTS WITH ALCOHOL USE DISORDER [PDF]

Y-J Hung, Chien‐Hung Chen, Shan Meng, H. P. Chang, S. J. Liu, L. Wu, Min‐Chuan Huang   +6 more
openalex   +1 more source

Machine Learning–Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention [PDF]

Majid Afshar, Emma J. Graham Linck, Alexandra B. Spicer, John Rotrosen, Elizabeth Salisbury‐Afshar, Pratik Sinha, Matthew W. Semler, Matthew M. Churpek   +7 more
openalex   +1 more source